FDA
approval
· 2021-05-14
FDA Approved: GAVILYTE-H AND BISACODYL — Supplemental Application (Lupin Pharmaceuticals, Inc.)
Summary
The FDA approved a supplemental application for Gavilyte-H and Bisacodyl, a combination laxative tablet containing polyethylene glycol 3350 with electrolytes an…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for GAVILYTE-H AND BISACODYL (POLYETHYLENE GLYCOL 3350, SODIUM CHLORIDE, SODIUM BICARBONATE, POTASSIUM CHLORIDE AND BISACODYL DELAYED-RELEASE TABLET)